Kurma Partners — 2020 Investments
6 investments dated 2020 · listed companies and verified rows first · show all
Synendos is a biotech company developing selective endocannabinoid reuptake inhibitors targeting the endocannabinoid system to treat neuropsychiatric disorders.
BiotechDeep TechDigital HealthMental HealthBasel, CH
Prof. Jürg Gertsch(Founder)Dr. Andrea Chicca(Co-Founder & Chief Executive Officer)Dr. Simon Russell(Co-Founder & Chief Commercial Officer)
Co-investorsYsios CapitalHigh Tech GruenderfondsSunstone Capital
ImCheck Therapeutics develops next-generation immunotherapeutic antibodies targeting the butyrophilin (BTN) and BTN-like (BTNL) superfamily of checkpoint molecules for immune system modulation.
BiotechHealthtech
Daniel Olive(Founder)in
Co-investorsAgent CapitalAndera PartnersPfizer Venture InvestmentsPureos BioventuresAlexandriaBpifrance+4 more
VICO provides AI-generated forecasts and event risk ratings that track and triangulate analyst views into continuous time series data.
AI & Machine LearningData & InfrastructureFintech
Co-investorsAIN VenturesMultiball CapitalDroia VenturesEQT Life SciencesEurazeoPureos Bioventures
VICO is an online platform for finding verified furnished monthly housing — rooms, studios, and apartments — aimed at students, young professionals, and digital nomads relocating to a new city.
B2B MarketplacesConsumerMarketplacesPropTechTravel & HospitalityMedellín, CO
Manuel FranzinTilman Burfeindin
Co-investors500 GlobalDroia VenturesEQT Life SciencesEurazeoPureos Bioventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Corlieve TherapeuticsLucine
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
















